This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H.
Right arrow Articles by Baumann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H.
Right arrow Articles by Baumann, H.

 Previous Article  |  Next Article 

Mol Cell Biol, March 1998, p. 1525-1533, Vol. 18, No. 3
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protein Tyrosine Phosphatase 2 (SHP-2) Moderates Signaling by gp130 but Is Not Required for the Induction of Acute-Phase Plasma Protein Genes in Hepatic Cells

Hongkyun Kim,1 Teresa S. Hawley,2 Robert G. Hawley,2 and Heinz Baumann1,*

Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263,1 and Oncology Gene Therapy Program, The Toronto Hospital, Toronto, Ontario M5G 2M1, Canada2

Received 29 August 1997/Returned for modification 30 September 1997/Accepted 17 November 1997

Signals propagated via the gp130 subunit of the interleukin-6 (IL-6)-type cytokine receptors mediate, among various cellular responses, proliferation of hematopoietic cells and induction of acute-phase plasma protein (APP) genes in hepatic cells. Hematopoietic growth control by gp130 is critically dependent on activation of both STAT3 and protein tyrosine phosphatase 2 (SHP-2). To investigate whether induction of APP genes has a similar requirement for SHP-2, we constructed two chimeric receptors, G-gp130 and G-gp130(Y2F), consisting of the transmembrane and cytoplasmic domains of gp130 harboring either a wild-type or a mutated SHP-2 binding site, respectively, fused to the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor. Rat hepatoma H-35 cells stably expressing the chimeric receptors were generated by retroviral transduction. Both chimeric receptors transmitted a G-CSF-induced signal characteristic of that triggered by IL-6 through the endogenous gp130 receptor; i.e., both activated the appropriate JAK, induced DNA binding activity by STAT1 and STAT3, and up-regulated expression of the target APP genes, those for alpha -fibrinogen and haptoglobin. Notwithstanding these similarities in the patterns of signaling responses elicited, mutation of the SHP-2 interaction site in G-gp130(Y2F) abrogated ligand-activated receptor recruitment of SHP-2 as expected. Moreover, the tyrosine phosphorylation state of the chimeric receptor, the associated JAK activity, and the induced DNA binding activity of STAT1 and STAT3 were maintained at elevated levels and for an extended period of time in G-gp130(Y2F)-expressing cells following G-CSF treatment compared to that in cells displaying the G-gp130 receptor. H-35 cells ectopically expressing G-gp130(Y2F) were also found to display an enhanced sensitivity to G-CSF and a higher level of induction of APP genes. Overexpression of the enzymatically inactive SHP-2 enhanced the signaling by the wild-type but not by the Y2F mutant G-gp130 receptor. These results indicate that gp130 signaling for APP gene induction in hepatic cells differs qualitatively from that controlling the proliferative response in hematopoietic cells in not being strictly dependent on SHP-2. The data further suggest that SHP-2 functions normally to attenuate gp130-mediated signaling in hepatic (and, perhaps, other) cells by moderating JAK action.


* Corresponding author. Mailing address: Roswell Park Cancer Institute, Department of Molecular and Cellular Biology, Elm and Carlton St., Buffalo, NY 14263. Phone: (716) 845-4587. Fax: (716) 845-8389. E-mail: baumann{at}sc3101.med.buffalo.edu.




This article has been cited by other articles:

  • Forbes, K., West, G., Garside, R., Aplin, J. D., Westwood, M. (2009). The Protein-Tyrosine Phosphatase, Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2, Is a Crucial Mediator of Exogenous Insulin-Like Growth Factor Signaling to Human Trophoblast. Endocrinology 150: 4744-4754 [Abstract] [Full Text]  
  • Kalliolias, G. D., Ivashkiv, L. B. (2008). IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38. J. Immunol. 180: 6325-6333 [Abstract] [Full Text]  
  • Chattopadhyay, S., Tracy, E., Liang, P., Robledo, O., Rose-John, S., Baumann, H. (2007). Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells. J. Biol. Chem. 282: 3014-3026 [Abstract] [Full Text]  
  • Bard-Chapeau, E. A., Yuan, J., Droin, N., Long, S., Zhang, E. E., Nguyen, T. V., Feng, G.-S. (2006). Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection. Mol. Cell. Biol. 26: 4664-4674 [Abstract] [Full Text]  
  • Sommer, U., Schmid, C., Sobota, R. M., Lehmann, U., Stevenson, N. J., Johnston, J. A., Schaper, F., Heinrich, P. C., Haan, S. (2005). Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation: CONTRIBUTIONS OF Src- AND RECEPTOR-TYROSINE KINASES. J. Biol. Chem. 280: 31478-31488 [Abstract] [Full Text]  
  • Arnaud, M., Crouin, C., Deon, C., Loyaux, D., Bertoglio, J. (2004). Phosphorylation of Grb2-Associated Binder 2 on Serine 623 by ERK MAPK Regulates Its Association with the Phosphatase SHP-2 and Decreases STAT5 Activation. J. Immunol. 173: 3962-3971 [Abstract] [Full Text]  
  • Jenkins, B. J., Grail, D., Inglese, M., Quilici, C., Bozinovski, S., Wong, P., Ernst, M. (2004). Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression. Mol. Cell. Biol. 24: 1453-1463 [Abstract] [Full Text]  
  • Bode, J. G., Schweigart, J., Kehrmann, J., Ehlting, C., Schaper, F., Heinrich, P. C., Haussinger, D. (2003). TNF-{alpha} Induces Tyrosine Phosphorylation and Recruitment of the Src Homology Protein-Tyrosine Phosphatase 2 to the gp130 Signal-Transducing Subunit of the IL-6 Receptor Complex. J. Immunol. 171: 257-266 [Abstract] [Full Text]  
  • Mahboubi, K., Kirkiles-Smith, N. C., Karras, J., Pober, J. S. (2003). Desensitization of Signaling by Oncostatin M in Human Vascular Cells Involves Cytoplasmic Tyr Residue 759 in gp130 but Is Not Mediated by Either Src Homology 2 Domain-containing Tyrosine Phosphatase 2 or Suppressor of Cytokine Signaling 3. J. Biol. Chem. 278: 25014-25023 [Abstract] [Full Text]  
  • Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R. M., Hortner, M., Friederichs, K., Behrmann, I., Tsiaris, W., Sasaki, A., Schneider-Mergener, J., Yoshimura, A., Neel, B. G., Heinrich, P. C., Schaper, F. (2003). SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130. J. Biol. Chem. 278: 661-671 [Abstract] [Full Text]  
  • Cebo, C., Durier, V., Lagant, P., Maes, E., Florea, D., Lefebvre, T., Strecker, G., Vergoten, G., Zanetta, J.-P. (2002). Function and Molecular Modeling of the Interaction between Human Interleukin 6 and Its HNK-1 Oligosaccharide Ligands. J. Biol. Chem. 277: 12246-12252 [Abstract] [Full Text]  
  • Mahboubi, K., Pober, J. S. (2002). Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells. COMPARISON OF INTERFERON-gamma AND ONCOSTATIN M. J. Biol. Chem. 277: 8012-8021 [Abstract] [Full Text]  
  • Tanuma, N., Shima, H., Nakamura, K., Kikuchi, K. (2001). Protein tyrosine phosphatase epsilon C selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling. Blood 98: 3030-3034 [Abstract] [Full Text]  
  • Deon, D., Ahmed, S., Tai, K., Scaletta, N., Herrero, C., Lee, I.-H., Krause, A., Ivashkiv, L. B. (2001). Cross-Talk Between IL-1 and IL-6 Signaling Pathways in Rheumatoid Arthritis Synovial Fibroblasts. J. Immunol. 167: 5395-5403 [Abstract] [Full Text]  
  • Miura, K., Saini, S. S., Gauvreau, G., MacGlashan, D. W. Jr (2001). Differences in Functional Consequences and Signal Transduction Induced by IL-3, IL-5, and Nerve Growth Factor in Human Basophils. J. Immunol. 167: 2282-2291 [Abstract] [Full Text]  
  • Bode, J. G., Fischer, R., Haussinger, D., Graeve, L., Heinrich, P. C., Schaper, F. (2001). The Inhibitory Effect of IL-1{beta} on IL-6-Induced {alpha}2-Macroglobulin Expression Is Due to Activation of NF-{kappa}B. J. Immunol. 167: 1469-1481 [Abstract] [Full Text]  
  • Watanabe, S., Zeng, R., Aoki, Y., Itoh, T., Arai, K.-i. (2001). Initiation of polyoma virus origin-dependent DNA replication through STAT5 activation by human granulocyte-macrophage colony-stimulating factor. Blood 97: 1266-1273 [Abstract] [Full Text]  
  • Stofega, M. R., Herrington, J., Billestrup, N., Carter-Su, C. (2000). Mutation of the SHP-2 Binding Site in Growth Hormone (GH) Receptor Prolongs GH-Promoted Tyrosyl Phosphorylation of GH Receptor, JAK2, and STAT5B. Mol. Endocrinol. 14: 1338-1350 [Abstract] [Full Text]  
  • Anhuf, D., Weissenbach, M., Schmitz, J., Sobota, R., Hermanns, H. M., Radtke, S., Linnemann, S., Behrmann, I., Heinrich, P. C., Schaper, F. (2000). Signal Transduction of IL-6, Leukemia-Inhibitory Factor, and Oncostatin M: Structural Receptor Requirements for Signal Attenuation. J. Immunol. 165: 2535-2543 [Abstract] [Full Text]  
  • Auernhammer, C. J., Melmed, S. (2000). Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function. Endocr. Rev. 21: 313-345 [Abstract] [Full Text]  
  • Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., Schaper, F. (2000). SOCS3 Exerts Its Inhibitory Function on Interleukin-6 Signal Transduction through the SHP2 Recruitment Site of gp130. J. Biol. Chem. 275: 12848-12856 [Abstract] [Full Text]  
  • Delahaye, L., Rocchi, S., Van Obberghen, E. (2000). Potential Involvement of FRS2 in Insulin Signaling. Endocrinology 141: 621-628 [Abstract] [Full Text]  
  • Schmitz, J., Dahmen, H., Grimm, C., Gendo, C., Muller-Newen, G., Heinrich, P. C., Schaper, F. (2000). The Cytoplasmic Tyrosine Motifs in Full-Length Glycoprotein 130 Have Different Roles in IL-6 Signal Transduction. J. Immunol. 164: 848-854 [Abstract] [Full Text]  
  • Paradis, H, Gendron, R. (2000). LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase. J. Cell Sci. 113: 4331-4339 [Abstract]  
  • Bode, J. G., Gatsios, P., Ludwig, S., Rapp, U. R., Haussinger, D., Heinrich, P. C., Graeve, L. (1999). The Mitogen-activated Protein (MAP) Kinase p38 and Its Upstream Activator MAP Kinase Kinase 6 Are Involved in the Activation of Signal Transducer and Activator of Transcription by Hyperosmolarity. J. Biol. Chem. 274: 30222-30227 [Abstract] [Full Text]  
  • Kim, H., Baumann, H. (1999). Dual Signaling Role of the Protein Tyrosine Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells. Mol. Cell. Biol. 19: 5326-5338 [Abstract] [Full Text]  
  • Lai, C.-f., Ripperger, J., Wang, Y., Kim, H., Hawley, R. B., Baumann, H. (1999). The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells. J. Biol. Chem. 274: 7793-7802 [Abstract] [Full Text]  
  • Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M., Hirano, T. (1999). STAT3 Is Required for the gp130-mediated Full Activation of the c-myc Gene. JEM 189: 63-73 [Abstract] [Full Text]  
  • Myers Jr., M. G., Mendez, R., Shi, P., Pierce, J. H., Rhoads, R., White, M. F. (1998). The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling. J. Biol. Chem. 273: 26908-26914 [Abstract] [Full Text]  
  • Sengupta, T. K., Talbot, E. S., Scherle, P. A., Ivashkiv, L. B. (1998). Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 95: 11107-11112 [Abstract] [Full Text]  
  • Coqueret, O., Gascan, H. (2000). Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275: 18794-18800 [Abstract] [Full Text]  
  • Wang, Y., Robledo, O., Kinzie, E., Blanchard, F., Richards, C., Miyajima, A., Baumann, H. (2000). Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor. J. Biol. Chem. 275: 25273-25285 [Abstract] [Full Text]  
  • Tanuma, N., Nakamura, K., Shima, H., Kikuchi, K. (2000). Protein-tyrosine Phosphatase PTPepsilon C Inhibits Jak-STAT Signaling and Differentiation Induced by Interleukin-6 and Leukemia Inhibitory Factor in M1 Leukemia Cells. J. Biol. Chem. 275: 28216-28221 [Abstract] [Full Text]  
  • Blanchard, F., Duplomb, L., Wang, Y., Robledo, O., Kinzie, E., Pitard, V., Godard, A., Jacques, Y., Baumann, H. (2000). Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase. J. Biol. Chem. 275: 28793-28801 [Abstract] [Full Text]  
  • Hermanns, H. M., Radtke, S., Schaper, F., Heinrich, P. C., Behrmann, I. (2000). Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR. J. Biol. Chem. 275: 40742-40748 [Abstract] [Full Text]  
  • Lelievre, E., Plun-Favreau, H., Chevalier, S., Froger, J., Guillet, C., Elson, G. C. A., Gauchat, J.-F., Gascan, H. (2001). Signaling Pathways Recruited by the Cardiotrophin-like Cytokine/Cytokine-like Factor-1 Composite Cytokine. SPECIFIC REQUIREMENT OF THE MEMBRANE-BOUND FORM OF CILIARY NEUROTROPHIC FACTOR RECEPTOR alpha COMPONENT. J. Biol. Chem. 276: 22476-22484 [Abstract] [Full Text]  
  • Terstegen, L., Gatsios, P., Bode, J. G., Schaper, F., Heinrich, P. C., Graeve, L. (2000). The Inhibition of Interleukin-6-dependent STAT Activation by Mitogen-activated Protein Kinases Depends on Tyrosine 759 in the Cytoplasmic Tail of Glycoprotein 130. J. Biol. Chem. 275: 18810-18817 [Abstract] [Full Text]